Misonix Announces New Distribution Agreement for Taiwan
FARMINGDALE, N.Y., Aug. 3, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new three-year exclusive distribution agreement with Grand Medical Instrument Co., Ltd., based in Taichung, Taiwan, R.O.C., for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter. The agreement provides Grand Medical with the rights to sell in Taiwan, R.O.C., and includes annual minimum purchase requirements. Open market sales will commence after product registration is completed by Grand Medical, which can take one year or longer.
Grand Medical has significant experience with launching capital equipment based surgical systems and is well known as a distributor of state-of-the-art medical devices, with special emphasis on Spine Surgery, Neurosurgery, and other skull-based surgeries.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.
"Misonix is quite pleased with the addition of Grand Medical to our ever-expanding roster of Asian specialty distributors. Their reputation as a high-